Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2018; 18(2):134-137
DOI: 10.5428/pcar20180214
Innovation of pharmaceutical care mode in foreign capital hospitals
1. ZHANG Xia(Department of Pharmacy,Shanghai Delta Health Hospital,Shanghai 201702,China lisaro71@163.com)
ABSTRACT  Objective: To study the innovative point of pharmaceutical care mode in foreign capital hospitals,summarize advanced experience and accelerate development of pharmaceutical care.Methods: Inductive analysis,investigation and on-the-spot investigation methods were used to survey the contents of pharmaceutical care in the three representative foreign capital hospitals and innovative points were summed up.Results: Besides general pharmaceutical care,the innovative points in foreign capital hospitals included: (1) supply of individualized special drugs; (2) preparation of individualized agents; (3) convenient supply of over-the-counter drugs and guidance; (4) preparation of electronic medication sheets; (5) consecutive medication management; (6) bed-side medication education before discharge from the hospital.Conclusion: Through innovative pharmaceutical care,foreign capital hospitals have gradually met patient demands on pharmaceutical care,and hopefully will bring enlightenment on the individualized development of pharmaceutical care in China.
Welcome to PCAR! You are the number 305 reader of this article!
Please cite this article as:
ZHANG Xia,. Innovation of pharmaceutical care mode in foreign capital hospitals[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(2): 134-137.
References:
1. LI YaTing,LIU SiHan,LI ShuMei.Exploration of the development of foreign capital hospitals in China[J].World Latest Med Inf(Elect Vers),2016,16(31):154,157.In Chinese.
2. Ministry of Health of the People’s Republic of China,State Administration of Traditional Chinese Medicine of the People’s Republic of China,Health Department of General Logistics Department of PLA.Notice on issuing regulations on pharmaceutical administration of medical institutions[EB/OL].(2011-03-30)[2017-12-01].http://www.nhfpc.gov.cn/mohyzs/s3585/201103/51113.shtml.In Chinese.
3. YANG JingXiu,GE ShengRong,ZHOU YuanYuan.Investigation of the utilization of oseltamivir in pediatric patients with influenza-like symptoms[J].China Pharmacy,2013,24(38):3634-3636.In Chinese with English abstract.
4. Rantucci M J.Pharmacists talking with patients:a guide to patient counseling[M].2nd ed.Mainly translated by DUAN JingLi.Beijing:People’s Military Medical Press,2012:4-5.In Chinese.
5. YANG Yong,TONG RongSheng.Medication reconciliation and clinical practice[J].Drug Eval,2011,8(2):14-16,26.In Chinese with English abstract.
6. ZHANG XiaoJuan,YANG Min.Effects of medication reconciliation in preventing medication errors of cardiovasology patients[J].Chin Pharm J,2013,48(3):234-236.In Chinese.
7. Dunn S P,Birtcher K K,Beavers C J,et al.The role of the clinical pharmacist in the care of patients with cardiovascular disease[J].J Am Coll Cardiol,2015,66(19):2129-2139.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口